CliffBio
small molecule

ONDANSETRON HYDROCHLORIDE

ONDANSETRON HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameONDANSETRON HYDROCHLORIDE
Active ingredientONDANSETRON HYDROCHLORIDE
StrengthEQ 2MG BASE/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalDecember 2006
Marketing statusDISCN

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.